Skip to main content
. 2011 Jun 30;66A(9):1030–1038. doi: 10.1093/gerona/glr097

Figure 1.

Figure 1.

Kaplan–Meier estimates of progression to AIDS-defining illness or death after highly active antiretroviral therapy (HAART) initiation among 472 men in the Multicenter AIDS Cohort Study who were AIDS-free at HAART initiation, stratified by (a) presence or absence of the frailty-related phenotype (FRP) in the 3 years before HAART or (b) according to the percentage of FRP visits in the 3 years before HAART (>25% vs ≤25%).